Prospects for the future include the possibility that when certain parts are needed, they can be fabricated within the same biologic system as an autogenous bone graft and then reapplied, particularly in discontinuity defects. This may benefit the patient with skeletal problems undergoing oncologic treatment or the patient with postoncologic deformities, as well as patients with post traumatic defects.
www.indiandentalacademy.com